-
Thematic Analysis
NewGeneric Drugs – Physician Perspective – Thematic Intelligence
Reasons to buy the ‘Generic Drugs – Physician Perspective’ thematic intelligence report: Assess healthcare professionals’ attitudes towards generic drugs prescription. Better understand the barriers to the production and uptake of generic medicines. Capture physicians’ opinions on generics substitution. Better understand patients’ preferences. Assess past and future generics uptake. Gain a better understanding of cost consideration when prescribing drugs. Explore the differences across markets. How is our ‘Generic Drugs – Physician Perspective’ report unique from other reports in the market? This...
-
Thematic Analysis
Inflation in Medical Devices – Thematic Intelligence
Inflation in Medical Devices Thematic Report Overview Even though COVID-19 vaccines and testing allowed economies and societies to safely reopen, supply-demand imbalance, inflation, recession prospects, market volatility, and geopolitical tensions and conflicts inject instability into the economic recovery and growth prospects. According to GlobalData’s Inflation Impact on the Healthcare Industry Survey (H2 2023), inflation, geopolitical conflicts, and reimbursement constraints may have the greatest negative impact on the medical device industry in 2024. These will have a reciprocal impact on healthcare...
-
Sector Analysis
Cell and Gene Therapies in Hemophilia A and B – Disease Overview, Treatment Options and Future Market Assessment
Cell and Gene Therapies (CGT) in Hemophilia A and B Market Report Overview The hemophilia A and B CGT market reached $12 million in 2023 with massive expansions across therapeutic areas. The CGT in Hemophilia A and B market research report will aid clients in gaining insight into the competitive landscape of leading CGT agents in Hemophilia A & B including launch date projections, key clinical trial analysis, analyst consensus forecasts, likelihood of approval analysis, and commentary on current and...
-
Thematic Analysis
Impact of Inflation on the Healthcare Sector, H2 2023 – Thematic Intelligence
Impact of Inflation on the Healthcare Sector Overview The wide availability of COVID-19 vaccines allowed economies and societies to safely reopen. However, factors such as supply-demand imbalance, inflation, recession prospects, market volatility, and geopolitical tensions and conflicts are hampering the economic recovery and growth prospects. These factors will have a reciprocal impact on healthcare services as well in 2024. The Impact of Inflation on the Healthcare Sector, H2 2023 report assesses inflation's impact on the treatment of patients and identifies...
-
Thematic Analysis
Biosimilars in Oncology – Thematic Intelligence
Accessing in-depth insights from the ‘Biosimilars in Oncology’ report will help you: Understand the milestones of biosimilars in oncology, the trends in the market, and the biosimilar value chain. Assess the marketed and pipeline products and their uptake across 8MM. Learn about the percentage of cancer patients treated with biosimilars, the price of the agents compared to their originator, and key opinion leaders’ outlook for the products. Examine the 8MM regulatory landscapes, their market potential, and their available and upcoming biosimilars....
-
Sector Analysis
Colorectal Cancer in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031
Colorectal Cancer Market Report Overview The colorectal cancer market sales across the 8MM were estimated at $15.8 billion in 2021. The market is expected to achieve a CAGR of more than 3% during 2021-2031. The global growth is driven by the anticipated approval and launch of 14 pipeline therapies and the label expansions of other agents. Colorectal cancer Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Colorectal cancer Market Forecast Download A Free Report...
-
Sector Analysis
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Female Contraceptives Market Report Overview The female contraceptives market sales across the 7MM was $7.8 billion in 2022. The market is expected to achieve a CAGR of less than 1% during 2022-2032. During the forecast period, sales of female contraceptives will increase in the UK due to the rising female population. Conversely, sales in France, Germany, Italy, and Spain markets will decrease owing to the declining female population. Female Contraceptives Market Outlook, 2022-2032 ($ Billion) Buy the Full Report to...
-
Sector Analysis
Gout Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Gout Market Report Overview The Gout market across the 7MM (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) was valued at $4.63 billion in 2022. Significant growth is expected at a CAGR of more than 8% from 2022 to 2032 as the gout population steadily increases and novel therapies enter the market. The US had the highest number of diagnosed prevalent cases of gout in 2022, followed by France and the UK. Gout is a form of...
-
Sector Analysis
Major Depressive Disorder in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2029
Major Depressive Disorder Market Report Overview The major depressive disorder (MDD) market sales across the 8 major markets (MM) were valued at $4.73 billion in 2019. The market is expected to achieve a CAGR of more than 7% during 2019-2029. The US market makes up the most total global sales due to the large MDD prevalent population, combined with the high price of medication in the country. Major Depressive Disorder Market Outlook, 2019-2029 ($ Billion) Buy the Full Report to...